Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RAMIPRIL
- Open-label, Multicenter, multinAtionaL, inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients
- Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions
- The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction
- Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions
- Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
- Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
- Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction
- Cross-over Study of Coronary Risk Factors With a Polypill
- Lokelma for RAAS Maximisation in CKD & Heart Failure.
- Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
- Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)
- Ramipril in Pediatric Patients on Hemodialysis
- Ramipril for the Treatment of COVID-19
- African American Study of Kidney Disease and Hypertension
- Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin
- Explorative Study for Treating Persistent Developmental Stuttering With Ramipril
- The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients
- Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus
- Effect of Some Drugs on Liver Fibrosis
- Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction
- Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
- The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI
- Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
- A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril
- Spironolactone on Acute Kidney Injury in Critically Ill Patients
- Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)
- An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event
- EMPRA (EMPagliflozin and RAs in Kidney Disease)
- Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
- Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
- Safety of Continuing CHemotherapy in Overt Left Ventricular Dysfunction Using Antibodies to HER-2
- Doxazosin and Ramipril in Hypertension
- Ramipril Treatment of Claudication
- Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension
- EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
- Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
- Perindopril vs Ramipril for Persistence in MAU Reduction Study
- Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study
- Secondary Prevention of Cardiovascular Disease in the Elderly Trial
- Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction
- REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial
- European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
- Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab
- Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers
- Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers
- Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers
- Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers
- Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD
- Sevelamer in Proteinuric CKD
- Aliskiren Study of Safety and Efficacy in Senior Hypertensives
- Ramipril for the Treatment of Oligospermia
- Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
- FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients
- Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
- The International Polycap Study 3 (TIPS-3)
- Cardiac Energetics and Function in Normal Human Ageing
- Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria
- Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome
- The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome
- An Open-labeled Trial of Ramipril in Patients With Migraine
- Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
- Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
- Aliskiren on Retinal Vasculature Treatment Study
- To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
- Relative Bioavailability of Empagliflozin (BI 10773) and Ramipril Administered Together Compared to Empagliflozin (BI 10773) and Ramipril Alone in Healthy Volunteers
- Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
- Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria
- Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial
- Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients
- Intensive Vasodilator Therapy in Patients With Essential Hypertension
- Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions
- Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions
- Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
- Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
- Ramipril 10 mg/Day Prevention
- Impact of Diabetes on Left Ventricular Remodeling
- Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
- Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria
- Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants
- A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure
- A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol
- Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's
- To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions
- To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions
- Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients
- Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
- Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure
- Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria
- Bioequivalence Study of Ramipril 10 mg Capsules Under Fed Conditions
- Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions
- A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions
- A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions
- A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce
- China Medical University Hospital (CMUH) Triapin Listing
- Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions
- Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
- Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
- Ramipril Versus Carvedilol in Duchenne and Becker Patients
- Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension
- Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.
- Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension
- Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i
- Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
- Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy
- Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
- Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)
- Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
- PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)
- Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients
- Telmisartan Versus Ramipril After Acute Coronary Syndrome
- Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions
- Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions
- Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease
- The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria
- Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril
- A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension
- Blood Pressure Lowering in Acute Stroke Trial (BLAST)
- Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
- The RAS, Fibrinolysis and Cardiopulmonary Bypass
- African American Study of Kidney Disease and Hypertension ABPM Pilot Study
- Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
- Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria
- Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome
- Nephropathy In Type 2 Diabetes and Cardio-renal Events
- Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
- Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
- Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina
- Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus
- Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
- To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients
- HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)
- Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension
- Prevention of Diabetes and Hypertension
- Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
- Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
- A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents
- Improving Outcomes in Patients With Kidney Disease Due to Diabetes
- A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly
- Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine
- Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
- Safety and Effects of Ramipril Combined With Candesartan
- Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
- Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
- Ramipril - Hypertension
- Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker
- Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension
- Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
- PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
- Ramipril in Rheumatoid Arthritis
- FOCUS:Focus On Coronary Unstable Syndromes
- Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes
- Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
- PHARES Study: Management of Resistant Hypertension
- Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients
- A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.
- A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.
- Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes
- The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease
- Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
- Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placeb
- Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)
- The Study of Atherosclerosis With Ramipril and Rosiglitazone
- Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
- Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
- The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
- Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
- Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
- Treatment of Pediatric Hypertension With Altace Trial
- Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
Clinical trials list
click for details